|
|||||
|
|
WP1066, a novel JAK2 inhibitor, suppresses proliferation and induces apoptosis in erythroid human cells carrying the JAK2 V617F mutation. |
|
| Authors: | Srdan Verstovsek Taghi Manshouri Alfonso Quintás-Cardama David Harris Jorge Cortes Francis J Giles Hagop Kantarjian Waldemar Priebe Zeev Estrov |
| Affiliation: | Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA. |
| Abstract: | |
| Keywords: | |